康宁杰瑞制药-B股票讨论区

$康宁杰瑞制药-B(09966.HK)$ 天天创历史新低，香港股市崩溃……

$康宁杰瑞制药-B(09966.HK)$ 敢敢往下跌📉，我在1块钱这等你来👍💪💪💪

$恒生指数(800000.HK)$ plunge deepened unceasingly after midday. It once stumbled 620 pts or 3.9% to bottom at 15,245, hitting an over-14-month low; last at 15,320, down 545 pts or 3.4%, with a total turnover of $88.5 billion.
Pharmaceuticals were sold off. $荣昌生物(09995.HK)$ once collapsed 27.5% to $22.8; last at $24.9, down 21%.
$三叶草生物-B(02197.HK)$ nosedived 9.6% to $0.47, hitting record low. $维亚生物(01873.HK)$ ...

$康宁杰瑞制药-B(09966.HK)$ 1块钱这等你来

交银国际认为，康宁杰瑞制药在NSCLC治疗领域的竞争日趋激烈，而且公司此前推迟的KN046-301试验数据读出及在ESMO 2023的相关数据更新，并未增加该行对其在NSCLC治疗成功开发的信心。

$康宁杰瑞制药-B(09966.HK)$ If corning & Jerry's late-stage data can validate the early-stage data, it means that first-line treatment of NSCLC(MOS estimated at more than 25 months in phase II) can obtain MOS data much higher than K

$康宁杰瑞制药-B(09966.HK)$$开拓药业-B(09939.HK)$$信达生物(01801.HK)$ Today Hong Kong pharmaceutical and biotech stocks fell 2.36%, industry groups in Hong Kong or top 5, kill the biological medicine market valuation, capital is still wary of innovative drug, exploit medicine, corning jerry that is called a fall, but has strong industry leading cinda biology, growth of 4.16% in the pharmaceutical sector in the first, Market money still likes and likes a few big champions.

$康宁杰瑞制药-B(09966.HK)$ Recist 41.9% and MRECist 60.5%, so 046 ORR may have a slight advantage, but the sample size is small